Neuropediatrics 2007; 38(6): 313-316
DOI: 10.1055/s-2008-1065355
Short Communication

© Georg Thieme Verlag KG Stuttgart · New York

Variable Phenotype Including Leigh Syndrome with a 9185T>C Mutation in the MTATP6 Gene

A.-M. Childs 1 , T. Hutchin 2 , K. Pysden 1 , L. Highet 1 , J. Bamford 3 , J. Livingston 1 , Y. J. Crow 2
  • 1Department of Paediatric Neurology, Leeds Teaching Hospitals Trust, Leeds General Infirmary, Leeds, West Yorkshire, U.K.
  • 2Leeds Institute of Molecular Medicine, University of Leeds, Leeds, West Yorkshire, U.K.
  • 3Department of Neurology, Leeds Teaching Hospitals Trust, Leeds General Infirmary, Leeds, West Yorkshire, U.K.
Weitere Informationen

Publikationsverlauf

received 16.07.2007

accepted 05.03.2008

Publikationsdatum:
06. Mai 2008 (online)

Abstract

We describe 15 members of a Caucasian family with an apparently homoplasmic T→C mutation at nucleotide position 9185 (9185T>C) in the mtDNA encoded MTATP6 (ATPase 6) gene. The clinical phenotype is extremely variable and includes late-onset Leigh syndrome (LS), isolated demyelinating peripheral neuropathy and neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP). Following recent reports of this same mutation in a single case and in a family with late-onset LS and NARP-like features, our paper emphasises the role of MTATP6 in LS and expands the associated clinical phenotype further.

References

  • 1 Castagna AE, Addis J, MacInnes RR. et al . Late onset Leigh syndrome and ataxia due to a T to C mutation at bp 9,185 of mitochondrial DNA.  Am J Med Genet. 2007;  143A 808-816
  • 2 Davis PC, Hoffman JC, Braun IF. et al . MR of Leigh's disease (subacute necrotising encephalomyelopathy).  AJNR Am J Neuroradiol. 1987;  8 71-75
  • 3 Leigh D. Subacute necrotizing encephalomyelopathy in an infant.  J Neurol Neurosurg Psychiat. 1951;  14 216-221
  • 4 Lyons G, Adams RD, Kolodny EH. Early infantile progressive metabolic encephalopathies: clinical problems and diagnostic considerations. Neurology of hereditary metabolic diseases of children. 2nd edn., New York: McGraw-Hill 1996
  • 5 Makino M, Horai S, Goto Y, Nonaka I. Mitochondrial DNA mutations in Leigh syndrome and their phylogenetic implications.  J Hum Genet. 2000;  45 69-75
  • 6 Moslemi A-R, Darin N, Tulinius M, Oldfors A, Holme E. Two new mutations in the MTATP6 gene associated with Leigh syndrome.  Neuropediatrics. 2005;  36 314-318
  • 7 Ogilvie I, Capaldi R. Mutations of the mitochondrially encoded ATPase 6 gene modeled in the ATP synthase of Escherichia coli.  FEBS Lett. 1999;  453 179-182
  • 8 Rahman S, Blok RB, Dahl HH. et al . Leigh syndrome: clinical features and biochemical and DNA abnormalities.  Ann Neurol. 1996;  39 343-351
  • 9 Santorelli FM, Mak SC, Vazquez-Memije E. et al . Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation.  Pediatr Res. 1996;  39 914-917
  • 10 Tatuch Y, Christodolou J, Feigenbaum A. et al . Heteroplasmic mtDNA mutation (TG) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.  Am J Hum Genet. 1992;  50 852-858

Correspondence

A.-M. Childs

Department of Paediatric Neurology

Leeds Teaching Hospitals Trust

B Floor

Clarendon Wing

The General Infirmary at Leeds

Belmont Grove

Leeds

West Yorkshire LS2 9NS

United Kingdom

Telefon: +44/113/392 31 13

Fax: +44/113/302 57 31

eMail: anne-marie.childs@leedsth.nhs.uk

    >